To evaluate the aptamer binding specificity to EpCAM, we determined the binding of PLD01, PLD02, and EpDT3, an RNA aptamer that is known to target EpCAM, on either EpCAM-positive HuCCT1 CCA cells or EpCAM-negative HL60 leukemia cells. Here, EPCAM is linked to cholangiocarcinoma.